{
    "2019-12-10": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Dips",
                        "Broader Markets"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-02-20",
                "original_text": "Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Investor Conference",
                        "Fourth-Quarter Results"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-12-10",
                "original_text": "Drug manufacturers have spent a record $342 billion on M&A in 2019",
                "features": {
                    "keywords": [
                        "Drug manufacturers",
                        "M&A",
                        "record spending"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-05",
                "original_text": "UPDATE 1-J&J CEO spurns U.S. congressional hearing on carcinogens in talc products",
                "features": {
                    "keywords": [
                        "J&J",
                        "CEO",
                        "congressional hearing",
                        "carcinogens",
                        "talc products"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}